Role of Imaging in the Evaluation of Minimal Residual Disease in Multiple Myeloma Patients

被引:26
作者
Zamagni, Elena [1 ]
Tacchetti, Paola [1 ]
Barbato, Simona [1 ]
Cavo, Michele [1 ]
机构
[1] Univ Bologna, Azienda Osped, Ist Ematol Seragnoli, Dipartimento Med Specialist Diagnost & Sperimenta, I-40138 Bologna, Italy
关键词
PET; CT; MRI; myeloma; prognosis; minimal residual disease; POSITRON-EMISSION-TOMOGRAPHY; CXCR4-DIRECTED ENDORADIOTHERAPY; DIFFUSION; PET/CT; MANAGEMENT; DIAGNOSIS; MRI; DARATUMUMAB; THERAPY;
D O I
10.3390/jcm9113519
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The International Myeloma Working Group (IMWG) recently introduced the evaluation of minimal residual disease (MRD) within the multiple myeloma (MM) response criteria, and MRD negativity assessed inside and outside the bone marrow is currently considered the most powerful predictor of favorable long-term outcomes. However, MRD evaluation has thus far relied on flow-cytometry or molecular-based methods, despite the limitations associated with the patchy infiltration of bone marrow (BM) plasma cells and the presence of extra-medullary (EMD). On the contrary, imaging-based sensitive response assessment through the use of functional rather than morphological whole-body (WB) imaging techniques, such as positron emission tomography with computed tomography (PET/CT) and magnetic resonance imaging (MRI), likely is a promising strategy to overcome these limitations in evaluating response to therapy and in the assessment of the MRD status in MM patients. However, despite the significant advances in the development and availability of novel functional imaging techniques for MRD evaluation, a worldwide standardization of imaging criteria for acquisition, interpretation, and reporting is yet to be determined and will be object of future investigations.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 47 条
[1]   The Role of Minimal Residual Disease Testing in Myeloma Treatment Selection and Drug Development: Current Value and Future Applications [J].
Anderson, Kenneth C. ;
Auclair, Daniel ;
Kelloff, Gary J. ;
Sigman, Caroline C. ;
Avet-Loiseau, Herve ;
Farrell, Ann T. ;
Gormley, Nicole J. ;
Kumar, Shaji K. ;
Landgren, Ola ;
Munshi, Nikhil C. ;
Cavo, Michele ;
Davies, Faith E. ;
Di Bacco, Alessandra ;
Dickey, Jennifer S. ;
Gutman, Steven I. ;
Higley, Howard R. ;
Hussein, Mohamad A. ;
Jessup, J. Milburn ;
Kirsch, Ilan R. ;
Little, Richard F. ;
Loberg, Robert D. ;
Lohr, Jens G. ;
Mukundan, Lata ;
Omel, James L. ;
Pugh, Trevor J. ;
Reaman, Gregory H. ;
Robbins, Michael D. ;
Sasser, A. Kate ;
Valente, Nancy ;
Zamagni, Elena .
CLINICAL CANCER RESEARCH, 2017, 23 (15) :3980-3993
[2]  
[Anonymous], 2013, BLOOD
[3]   F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma [J].
Bartel, Twyla B. ;
Haessler, Jeff ;
Brown, Tracy L. Y. ;
Shaughnessy, John D., Jr. ;
van Rhee, Frits ;
Anaissie, Elias ;
Alpe, Terri ;
Angtuaco, Edgardo ;
Walker, Ronald ;
Epstein, Joshua ;
Crowley, John ;
Barlogie, Bart .
BLOOD, 2009, 114 (10) :2068-2076
[4]   Impact of PET-CT Response on Survival Parameters Following Autologous Stem Cell Transplantation Among Patients with Multiple Myeloma: Comparison of Two Cut-Off Values [J].
Beksac, Meral ;
Gunduz, Mehmet ;
Ozen, Mehmet ;
Ozturk, Sule Mine Bakanay ;
Kucuk, Ozlem ;
Ozkan, Elgin .
BLOOD, 2014, 124 (21)
[5]   Extramedullary involvement in multiple myeloma [J].
Blade, Joan ;
Fernandez de Larrea, Carlos ;
Rosinol, Laura .
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (11) :1618-1619
[6]   Copper 64-labeled daratumumab as a PET/CT imaging tracer for multiple myeloma [J].
Caserta, Enrico ;
Chea, Junie ;
Minnix, Megan ;
Viola, Domenico ;
Vonderfecht, Steven ;
Yazaki, Paul ;
Crow, Desiree ;
Khalife, Jihane ;
Sanchez, James F. ;
Palmer, Joycelynne M. ;
Hui, Susanta ;
Carlesso, Nadia ;
Keats, Jonathan ;
Kim, Young ;
Buettner, Ralf ;
Marcucci, Guido ;
Rosen, Steven ;
Shively, John ;
Colcher, David ;
Krishnan, Amrita ;
Pichiorri, Flavia .
BLOOD, 2018, 131 (07) :741-745
[7]   Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group [J].
Cavo, Michele ;
Terpos, Evangelos ;
Nanni, Cristina ;
Moreau, Philippe ;
Lentzsch, Suzanne ;
Zweegman, Sonja ;
Hillengass, Jens ;
Engelhardt, Monika ;
Usmani, Saad Z. ;
Vesole, David H. ;
San-Miguel, Jesus ;
Kumar, Shaji K. ;
Richardson, Paul G. ;
Mikhael, Joseph R. ;
da Costa, Fernando Leal ;
Dimopoulos, Meletios-Athanassios ;
Zingaretti, Chiara ;
Abildgaard, Niels ;
Goldschmidt, Hartmut ;
Orlowski, Robert Z. ;
Chng, Wee Joo ;
Einsele, Hermann ;
Lonial, Sagar ;
Barlogie, Bart ;
Anderson, Kenneth C. ;
Rajkumar, S. Vincent ;
Durie, Brian G. M. ;
Zamagni, Elena .
LANCET ONCOLOGY, 2017, 18 (04) :E206-E217
[8]   Treatment to suppression of focal lesions on positron emission tomography-computed tomography is a therapeutic goal in newly diagnosed multiple myeloma [J].
Davies, Faith E. ;
Rosenthal, Adam ;
Rasche, Leo ;
Petty, Nathan M. ;
McDonald, James E. ;
Ntambi, James A. ;
Steward, Doug M. ;
Panozzo, Susan B. ;
van Rhee, Frits ;
Zangari, Maurizio ;
Schinke, Carolina D. ;
Thanendrarajan, Sharmilan ;
Walker, Brian ;
Weinhold, Niels ;
Barlogie, Bart ;
Hoering, Antje ;
Morgan, Gareth J. .
HAEMATOLOGICA, 2018, 103 (06) :1047-1053
[9]   Prediction of Progression-Free Survival in Patients With Multiple Myeloma Following Anthracycline-Based Chemotherapy Based on Dynamic FDG-PET [J].
Dimitrakopoulou-Strauss, Antonia ;
Hoffmann, Martin ;
Bergner, Raoul ;
Uppenkamp, Michael ;
Haberkorn, Uwe ;
Strauss, Ludwig G. .
CLINICAL NUCLEAR MEDICINE, 2009, 34 (09) :576-584
[10]   Role of Magnetic Resonance Imaging in the Management of Patients With Multiple Myeloma: A Consensus Statement [J].
Dimopoulos, Meletios A. ;
Hillengass, Jens ;
Usmani, Saad ;
Zamagni, Elena ;
Lentzsch, Suzanne ;
Davies, Faith E. ;
Raje, Noopur ;
Sezer, Orhan ;
Zweegman, Sonja ;
Shah, Jatin ;
Badros, Ashraf ;
Shimizu, Kazuyuki ;
Moreau, Philippe ;
Chim, Chor-Sang ;
Lahuerta, Juan Jose ;
Hou, Jian ;
Jurczyszyn, Artur ;
Goldschmidt, Hartmut ;
Sonneveld, Pieter ;
Palumbo, Antonio ;
Ludwig, Heinz ;
Cavo, Michele ;
Barlogie, Bart ;
Anderson, Kenneth ;
Roodman, G. David ;
Rajkumar, S. Vincent ;
Durie, Brian G. M. ;
Terpos, Evangelos .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (06) :657-U186